Clinics in Laboratory Medicine

Papers
(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Molecular Pathology of Ovarian Epithelial Neoplasms25
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture24
Forthcoming Issues21
Digital Imaging and AI Pre-classification in Hematology18
Promoting Health Equity Through Effective Laboratory Stewardship Strategies15
Current Topics in Molecular Diagnostics and Precision Medicine13
Molecular Detection of Oncogenic Gene Rearrangements13
Contributors12
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists11
Point-of-Care Drug Testing11
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities10
Molecular Oncology Diagnostics10
Copy Number Analysis in Cancer Diagnostic Testing10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory10
Is It Possible to Test for Viral Infectiousness?10
Contributors9
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation9
Contributors9
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders8
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management8
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine8
Opportunities and Challenges with Artificial Intelligence in Genomics8
Cell-free Nucleic Acids in Cancer8
Flow Cytometry and Platelets8
Contents7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests7
Artificial Intelligence for Clinical Flow Cytometry7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP537
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology7
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing7
Contents7
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-196
Copyright6
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe6
The Evolving Role of Molecular Diagnostics in Pathology5
Steps Forward to a Fair and Inclusive Blood Supply5
Molecular Biomarkers of Response to Cancer Immunotherapy5
Point of Care Molecular Testing5
Molecular Alterations in Pediatric Solid Tumors5
Molecular Diagnostics for Invasive Molds: From Lab to Bedside5
Electronic Health Record Optimization for Artificial Intelligence5
Utility of Single-Gene Testing in Cancer Specimens5
Morphologic Characteristics of Myelodysplastic Syndromes5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness5
Copyright5
The Mass Spectrometry Revolution in Clinical Microbiology Part 25
Taking Center Stage4
Rapid Antigen Assays for SARS-CoV-24
Diagnostic Stewardship for Multiplex Respiratory Testing4
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-24
Artificial Intelligence in the Clinical Laboratory4
Contributors4
Copyright4
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults4
Copyright4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)4
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation4
Contents4
Analytical Principles of Cancer Next Generation Sequencing3
Contents3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility3
Contents3
Molecular Pathology of Breast Tumors3
Updates in Blood Banking and Transfusion Medicine3
History, Advances, and Challenges of Sickle Cell Disease Treatment3
Pathology Clinics Can Address Pathology Burnout3
Copyright3
Transfusion Medicine Informatics3
Transfusion Reactions and Adverse Events3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels3
Childhood Myelodysplastic Syndrome3
Promoting Gender Equality in Pathology and Laboratory Medicine Leadership3
Molecular Methods3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology3
Update on Ovarian Sex Cord–Stromal Tumors3
A Winding Road to Health Care Equity in Sickle Cell Disease3
0.16275382041931